Metraipolis › archive › dc_05f65e7cfbb5

Flexible Risk Evidence Combination Rules in Breast Cancer Precision Therapy — Europe PMC PMID:36675780

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36675780
DOI
10.3390/jpm13010119
License (as archived)
solo-consultazione
Archived
2026-10-08T09:30:01.033Z
SHA-256 of the archived text
c466f7d6514e8f391f14ee6b57f0ad2fa117cbfa2053d421bd8d53ba22074c79
Stable URL of this page
https://metraipolis.com/documento/dc_05f65e7cfbb5

How to cite

Flexible Risk Evidence Combination Rules in Breast Cancer Precision Therapy — Europe PMC PMID:36675780 — Europe PMC (en), https://europepmc.org/article/MED/36675780 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_05f65e7cfbb5 (Metraipolis archive dc_05f65e7cfbb5, sha256 c466f7d6514e8f391f14ee6b57f0ad2fa117cbfa2053d421bd8d53ba22074c79)
BibTeX
@misc{dc05f65e7cfbb5,
  title = {Flexible Risk Evidence Combination Rules in Breast Cancer Precision Therapy — Europe PMC PMID:36675780},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36675780},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_05f65e7cfbb5; sha256 c466f7d6514e8f391f14ee6b57f0ad2fa117cbfa2053d421bd8d53ba22074c79},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/36675780. Agents can read the archived copy with the MCP tool read_document.